IP Library Granted Patent US 9,498,469
Granted Patent B2
US 9,498,469 · App. 14/445,530 · Granted Nov 22, 2016

Compositions and methods for enhancing brain function

Inventor: Josh Reynolds (Laguna Beach, CA)
Assignee: KeyView Labs, Inc.
A61K31/439A23L33/105A23L33/175A23L33/21A61K9/0053A61K9/28A61K9/50A61K31/19A61K31/197A61K31/205A61K31/22A61K31/221A61K31/385A61K31/4188A61K31/4375A61K31/473A61K31/4748A61K36/41A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,498,469
App. No.
14/445,530
Granted
Nov 22, 2016
Kind
B2
Abstract

Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola, and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola, and biotin.

Claims (30)

1. A nutritional supplement composition for enhancing cognitive function, comprising:

huperzine A;

rhodiola; and

acetyl-L-carnitine;

wherein the composition is formulated for oral administration such that huperzine A, acetyl-L-carnitine, and rhodiola together account for at least 80 wt % of a dosage unit of the composition and the rhodiola is about 11.0% to about 22.0% by weight of the huperzine A, acetyl-L-carnitine and rhodiola, and the rhodiola and acetyl-L-carnitine are in a ratio of y:z respectively, wherein y is between about 1,600 and 2,400 for rhodiola and z is between about 8,000 and 12,000 for acetyl-L-carnitine.

2. The nutritional supplement composition of claim 1 , wherein the huperzine A, rhodiola, and acetyl-L-carnitine are in a ratio of x:y:z, respectively, wherein x is between about 0.8 and about 1.2, y is between about 1,600 and about 2,400 for rhodiola, and z is between about 8,000 and about 12,000.

3. The nutritional supplement composition of claim 2 , wherein x is between about 0.9 and about 1.1, y is between about 1,800 and about 2,200 for rhodiola, and z is between about 9,000 and about 11,000.

4. The nutritional supplement composition of claim 1 , wherein acetyl-L-carnitine is present in an amount from about 1250 mg to about 2000 mg.

5. The nutritional supplement composition of claim 1 , wherein rhodiola is present in an amount from about 250 mg to about 350 mg.

6. The nutritional supplement composition of claim 1 , wherein huperzine A is present in an amount from about 50 mcg to about 200 mcg.

7. The nutritional supplement composition of claim 1 , wherein the composition is formulated with an enteric coating.

8. The nutritional supplement composition of claim 1 , further comprising an inactive ingredient selected from the group consisting of a carrier, a binder, an excipient, a dye, and combinations thereof.

9. The nutritional supplement composition of claim 1 , wherein huperzine A, rhodiola, and acetyl-L-carnitine together account for at least 90 wt % of a dosage unit of the composition.

10. The nutritional supplement composition of claim 1 , wherein huperzine A, rhodiola, and acetyl-L-carnitine together account for at least 95 wt % of the dosage unit of the composition.

11. The nutritional supplement composition of claim 1 , wherein the dosage unit of the composition is equal or less than 1,200 mg.

12. A method of assisting enhancement of cognitive function in a person, comprising administering the nutritional supplement composition of claim 1 .

13. A nutritional supplement composition for enhancing cognitive function, comprising:

huperzine A;

rhodiola;

acetyl-L-carnitine;

biotin,

alpha lipoic acid; and

wherein the composition is formulated for oral administration such that the huperzine A, rhodiola, acetyl-L-carnitine, biotin, and alpha lipoic acid together account for at least 80 wt % of a dosage unit of the composition and the rhodiola is about 7.0 to 20.0 percent by weight of the huperzine A, rhodiola, acetyl-L-carnitine, biotin and alpha lipoic acid and the alpha lipoic acid is about 11.0 to 25.0 percent by weight of the huperzine A, rhodiola, acetyl-L-carnitine biotin and alpha lipoic acid, and the rhodiola and acetyl-L-carnitine are in a ratio of y:z respectively, wherein y is between about 1,600 and 2,400 for rhodiola and z is between about 8,000 and 12,000 for acetyl-L-carnitine.

14. The nutritional supplement composition of claim 13 , wherein acetyl-L-carnitine is present in an amount from about 1250 mg to about 2000 mg.

15. The nutritional supplement composition of claim 13 , wherein rhodiola is present in an amount from about 200 mg to about 400 mg.

16. The nutritional supplement composition of claim 13 , wherein huperzine A is present in an amount from about 50 mcg to about 200 mcg.

17. The nutritional supplement composition of claim 13 , further comprising alpha lipoic acid in an amount of about 300 mg to about 500 mg.

18. The nutritional supplement composition of claim 13 , further comprising biotin in an amount of about 400 mcg to about 600 mcg.

19. The nutritional supplement composition of claim 13 , wherein the dosage unit of the composition is equal or less than 1,200 mg.

20. A method of assisting enhancement of cognitive function in a person, comprising administering the nutritional supplement composition of claim 13 .

Assignments (1)
SECURITY INTEREST Recorded Jun 21, 2017
From: KEYVIEW LABS, INC.
To: PACIFIC WESTERN BANK, AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK
Reel/Frame 042769/0690 →
Continuity (5)
Continuation 13307587 · Nov 30, 2011
Continuation In Part 11758151 · Jun 5, 2007
Provisional Application 60803943 · Jun 5, 2006
Provisional Application 60820201 · Jul 24, 2006
Related Publication 20140335191A1 · Nov 13, 2014